These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2153637)

  • 1. Tumour cells which develop resistance to cytolysis by tumour necrosis factor have a different glycoform of a 105-kDa glycoprotein and lose the capacity to invade and metastasize.
    Neale ML; Fiera RA; Matthews N
    Int J Cancer; 1990 Jan; 45(1):203-8. PubMed ID: 2153637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between tumour cell morphology, gap junctions and susceptibility to cytolysis by tumour necrosis factor.
    Matthews N; Neale ML
    Br J Cancer; 1989 Feb; 59(2):189-93. PubMed ID: 2930684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells.
    Matsuda M; Masutani H; Nakamura H; Miyajima S; Yamauchi A; Yonehara S; Uchida A; Irimajiri K; Horiuchi A; Yodoi J
    J Immunol; 1991 Dec; 147(11):3837-41. PubMed ID: 1719091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.
    Yoshie O; Tada K; Ishida N
    J Biochem; 1986 Sep; 100(3):531-41. PubMed ID: 3023310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor.
    Neale ML; Fiera RA; Matthews N
    Immunology; 1988 May; 64(1):81-5. PubMed ID: 3133309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of interferon-gamma and tumor necrosis factor-alpha on antiviral activity and (2'-5') oligo (A) synthetase induction in a myelomonocytic cell line.
    Wietzerbin J; Gaudelet C; Catinot L; Chebath J; Falcoff R
    J Leukoc Biol; 1990 Aug; 48(2):149-55. PubMed ID: 2164556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of chronic myelomonocytic leukaemia to acute myeloid leukaemia with expression of tumour necrosis factor-α and its receptors.
    Nakayama-Ichiyama S; Yokote T; Iwaki K; Takubo T; Tsuji M; Hanafusa T
    Br J Haematol; 2011 May; 153(4):419. PubMed ID: 21457217
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors.
    Shalaby MR; Sundan A; Loetscher H; Brockhaus M; Lesslauer W; Espevik T
    J Exp Med; 1990 Nov; 172(5):1517-20. PubMed ID: 2172437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
    Mutch DG; Powell CB; Kao MS; Collins JL
    Cancer Res; 1992 Feb; 52(4):866-72. PubMed ID: 1737348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of tumour cell resistance to tumour necrosis factor does not confer resistance to cytotoxic drugs.
    Neale ML; Matthews N
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):133-7. PubMed ID: 2493381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between multidrug resistance and tumor necrosis factor resistance in an EL4 cell line model.
    Ujhazy P; Chen YF; Fredericks W; Ho RL; Mihich E; Baker RM; Ehrke MJ
    Cancer Commun; 1990; 2(5):181-8. PubMed ID: 1973358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polar agents with differentiation-inducing capacity prime myelomonocytic cell lines to lipopolysaccharide-induced cytolysis: the role of endogenous tumor necrosis factor.
    Depraetere S; Joniau M
    Leukemia; 1994 Nov; 8(11):1951-9. PubMed ID: 7967741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of resistance to tumor necrosis factor].
    Pfreundschuh M; Genth B; Kirchner H; Scheurich P; Lindemann A; Steinmetz HT; Schaadt M; Diehl V
    Onkologie; 1989 Jun; 12(3):128-30. PubMed ID: 2548141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonial morphology of tumour cells and susceptibility to cytolysis by tumour necrosis factor. The role of cellular fibronectin deposition in the extracellular matrix.
    Neale ML; Matthews N
    Br J Cancer; 1990 Jun; 61(6):831-5. PubMed ID: 2372484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.
    Espevik T; Brockhaus M; Loetscher H; Nonstad U; Shalaby R
    J Exp Med; 1990 Feb; 171(2):415-26. PubMed ID: 1689365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
    Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 regulates the cytotoxic effect of tumour necrosis factor on U937 cells.
    Cairns JA; Guy GR; Tan YH
    Immunology; 1992 Apr; 75(4):669-73. PubMed ID: 1317349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two U937 cell sublines exhibiting different patterns of response to tumour necrosis factor.
    Kaszubowska L; Engelmann H; Gotartowska M; Iliszko M; Bigda J
    Cytokine; 2001 Mar; 13(6):365-70. PubMed ID: 11292320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
    Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
    Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.